Clinical Research Access The company specializes in enabling urgent care centers with no prior clinical trial experience to participate in trials, which creates a scalable channel for sponsors seeking diverse patient populations and faster enrollment.

Ancillary Revenue By embedding experienced investigators and study coordinators in urgent care practices, No Resistance converts trial activity into a revenue share from subject-specific fees, offering clinics a new income stream without disrupting normal operations.

Partnership Model The firm acts as a bridge among urgent care operators, sponsors, and trial sites, positioning as a turnkey solution that reduces administrative burden for clinics and accelerates enrollment, a compelling value proposition for Sponsor BD teams.

Tech Enablement Leveraging a tech stack with cloud services, caching, CDN, analytics tools, and embedded content delivery suggests opportunities to upsell integrated trial IT infrastructure, data capture, and patient engagement capabilities to streamline studies.

Market Positioning Operating within hospitals and health care with a mid-sized workforce, No Resistance can target mid-market urgent care networks and regional health systems as scalable partners for multi-site trials, presenting a path to rapid expansion and portfolio diversification.